Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
Immatics Enters Strategic Partnership With Genmab July 8, 2018
Immatics Biotechnologies GmbH recently announced it has entered into a research collaboration and license agreement with Genmab A/S to develop next-generation, T-cell engaging bispecific immunotherapies targeting multiple cancer indications.
PEPTIDE DELIVERY – The Endometriosis Enigma – Why Can’t There Be a Pill for That? June 4, 2018
Joel Tune, MBA, says for those peptide therapeutics that meet the necessary criteria, advances in formulation technologies coupled with favorable market dynamics will continue to drive interest across the entire prescription drug spectrum for safe and effective orally administered peptide therapeutics.
INTEGRATED DELIVERY SYSTEMS – The Value of an Integrated System for Combination Products May 31, 2018
Theresa Bankston, PhD, says the fact that many of these therapies are designed for home delivery by patients or caregivers via subcutaneous injection, combined with increasing complexity of longer-acting formulations, larger injection volumes, and longer injection durations, has raised the bar for seamless injection delivery technology.
Emisphere Amends License Agreement with Novo Nordisk; Will Receive $7 Million April 26, 2018
Emisphere Technologies, Inc. recently announced that it has amended its existing 2015 Development and License Agreement with Novo Nordisk A/S for...SPECIAL FEATURE – Challenging Molecules Drive Developers to Get More Creative With Excipients April 2, 2018
Contributor Cindy H. Dubin highlights the techniques various excipient manufacturers are using to develop more innovative and effective ingredients to improve the performance of drug molecules.
3D PRINTING – 3D Printed Drugs Hold Great Potential for Personalized Medicine March 15, 2018
Contributor Cindy H. Dubin explores 3D printed drugs in the wake of a milestone in the pharma industry when Aprecia Pharmaceuticals’ Spritam (levetiracetam) tablets became the first FDA-approved prescription drug product manufactured using 3D printing technology.
GAS-POWERED DELIVERY – Innovating Injectable Devices to Deliver Today’s Pharmaceuticals March 15, 2018
Steven Kaufman believes that with autoinjectors in high demand by the biopharma industry, gas-powered delivery systems may have the solution to many of the difficulties the industry is facing.
SPECIAL FEATURE – Improving Bioavailability & Solubility: A Top-Down Versus Bottom-Up Approach March 15, 2018
Contributor Cindy H. Dubin speaks with several innovative companies on their science, techniques, and technologies aimed at improving bioavailability and solubility.
BioCryst & Idera Announce Merger to Combine Capabilities January 29, 2018
BioCryst Pharmaceuticals, Inc. and Idera Pharmaceuticals, Inc. recently announced they have signed a definitive merger agreement to form a new...SPECIAL FEATURE – Analytical Testing – Contractors Take on the Challenge of Complex Molecules January 9, 2018
Contributor Cindy H. Dubin highlights some of the analytical testing services that leading contractors offer aimed at the increasing complexities of today’s pharmaceutical pipelines.
FOAMED SILICONE – Molded Porous Silicone for Delivery of Macromolecules & Low-Solubility APIs January 9, 2018
James Arps, PhD, and Matt Petersen, PhD, investigate how foamed silicone is capable of sustained, controlled elution of hydrophobic small molecule and large macromolecular payloads.
pSivida & Nicox Enter Strategic Collaboration Agreement to Develop Sustained Release Drug October 17, 2017
pSivida Corp., a leader in the development of sustained release drug products and technologies, and Nicox S.A., the international ophthalmic...ADVANCED DELIVERY DEVICES – The Staked Needle Pre-Filled Syringe: Benefits, Conventional Limitations & a New Approach October 2, 2017
Horst Koller and John A. Merhige, MEM, say the advantages of a Staked Needle Pre-Filled Syringe are clear and well documented, but significant risks remain. A new alternative is now available that addresses the known challenges and adds critical usability and safety features while preserving existing components and processes.
Inspyr Therapeutics & Lewis and Clark Pharmaceuticals Complete Merger September 18, 2017
Inspyr Therapeutics and Lewis and Clark Pharmaceuticals recently announced the successful completion of a merger to create an integrated biotechnology...SPECIAL FEATURE – Injectable Drug Delivery: New Technologies Deliver Biologics & Differentiate Brands September 12, 2017
Contributor Cindy H. Dubin reports on a segment of the drug delivery industry that will see its market revenue double in just 5 years in response to a growing need to deliver highly viscous, high-volume drugs.
Genmab & Seattle Genetics to Co-Develop Tisotumab Vedotin for Solid Tumors September 5, 2017
Genmab A/S and Seattle Genetics, Inc. recently announced that Seattle Genetics, Inc. has exercised its option to co-develop tisotumab vedotin....Rexahn Pharmaceuticals Receives New US Patent September 5, 2017
Rexahn Pharmaceuticals, Inc. recently announced that the United States Patent and Trademark Office has issued US Patent No. 9,744,167, Nanoparticulate...Enteris Biopharma Doses First Woman in Phase 2a Clinical Trial August 28, 2017
Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies, recently announced the first...Aptevo Therapeutics Highlights ADAPTIR™ Protein Therapeutic Platform June 12, 2017
Aptevo Therapeutics Inc. recently announced that aspects of its ADAPTIR protein therapeutic platform were showcased recently at the Americas Antibody...SPECIAL FEATURE – Wanted: New Excipients to Meet the Demands of a Challenging Industry June 1, 2017
Contributor Cindy H. Dubin recently spoke with some of the leading excipient innovators to find out what types of excipients they are developing, the advantages they offer to formulations, and where they see the industry focusing throughout the next few years.